ArticleCancer medicine2018

Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β-catenin signaling and sensitizes cancer cells to FH535 therapy.

Duo Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.